HOME >> Reports in Clinical Studies and Medicine

About This Journal

Reports in Clinical Studies and Medicine is a peer-reviewed open access journal publishes all original research and review article covering all aspects of clinical studies and clinical trials. The primary aims of journal are to cover the development in clinical trial/studies. Short communications and commentaries on the current development of the clinical studies are welcome.

Topics of interest include, but are not limited to:

  • Design of clinical studies
  • Methodology in clinical studies
  • Regulation aspects of clinical trials
  • Bioethics
  • Data analysis of clinical studies
  • Management and policy in clinical studies
ISSN(Online): XXXX-XXXX
ISSN(Print): XXXX-XXXX

Editorial Board

Editor-in-Chief

Prof. Ramesh P Aacharya, Tribhuvan University Teaching Hospital Institute of Medicine Maharajgunj, Nepal

Editorial Board

Prof. Nicolas Pinsault, Grenoble-Alpes University, France

Prof. Ricardo Horacio Illia, Obstetrics & Gynecology, Hospital Aleman, Argentina

Dr. Nuno Manuel Félix, Hospital Distrital de Santarém, Portugal

Dr. Md Kaiissar Mannoor, Institute for Developing Science and Health, Bangladesh

Ms. Rafaela Fernandes Zancan, University of Sao Paulo, Brazil

Luz María Rodeles Antonelli, National University of Litoral, Argentina

Dr. Jia Cheng, Zhongshan Hospital, Xiamen University, China

Dr. Zahra Azizi, Iran University of Medical Sciences, Iran

Dr. Yuanwen Ding, Department of Spine Surgery, The Third Hospital of Hebei Medical University

Dr. Xinping Tian, Department of Rheumatology Peking Union Medical College Hospital, China

Focus and Scope

Reports in Clinical Studies and Medicine is a peer-reviewed, gold Open Access journal that focuses on current clinical investigations that explore novel or improved medical strategies and treatments, along with their corresponding results and analyses. This may include the clinical trials of both drug-based and non-drug therapies, medical aid devices, as well as alternative clinical programs and treatment modalities.

We particularly welcome impactful clinical studies that highlight the progress made in region-specific or under-reported areas, in addition to practical and scalable solutions that effectively address serious global health issues. We aim to publish topics that include:

  • The design and validation of clinical studies
  • The methodologies, regulation, and ethical concerns of clinical trials
  • The data analysis and deduction of clinical results
  • The creation and management of evidence-based health policies

RCSM accepts original research articles, reviews, short communications, as well as opinions and commentaries. The journal targets a broad readership of clinicians, medical specialists, statisticians, physicians, as well as policymakers.

For Authors

  • The journal will not accept manuscript that has been published or is under consideration for publication in any other journal. The author needs to notify the journal if the data presented in the manuscript has been ever presented in conferences.
  • The author has to provide the authorization of no conflict of interest with any financial body or funding agency that might influence the results or interpretation of their manuscript. All authors, members, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. The corresponding author must download and complete the ICMJE Conflict of Interest Form on behalf of all the authors regarding to potential conflicts of interest, and submit the form in Step 4 during the article submission process.
  • All articles should be written in English—either British or American as long as consistency is observed. SI units should be used. If you are not a native speaker of English you may want to utilize the professional language editing service provided by us before submitting the final version.
  • If you decide to withdrawal your manuscript after it has been accepted (but not yet published), a processing fee of USD 200 is chargeable upon withdrawal.
  • The journal will not accept manuscripts that are plagiarized in any circumstances. The journal will verify the originality of the submitted manuscripts with iThenticate, the plagiarism detection software.

    If a manuscript uses a text copied directly from another source, this text must be written in quotation marks and original source must be cited. If any kind of plagiarism is detected during the review process, the manuscript will be rejected.

    Authors and researchers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com.

  • PiscoMed Publishing requests all members involved in the journal publishing process to adhere the “Code of Conduct for Editors” and “Code of Conduct for Publishers” as stipulated by COPE (Committee on Publication Ethics). The guidelines define the best practice in the ethics of scholarly publishing, aiding the journals and publishers to achieve this.
  • Units of measurement should be presented simply and concisely using System International (SI) units.
  • Cover Letter
    The cover letter is necessary for each submission. The cover letter should be uploaded as a separate file in Step 4 during the submission. The contents of the cover letter should include brief explanation of what was previously known, the conceptual advancement with the findings and its significance to broad readership. The cover letter will only be visible to the editor. Reviewers will not have access to the cover letter.

    Title
    The title should capture the conceptual significance for a broad audience. The title should not be more than 50 words and should be able to give readers an overall view of the paper’s significance. Titles should avoid using uncommon jargons, abbreviations and punctuations.

    Abstract
    The abstract should provide a brief summary of the paper. It should not contain any non-standard abbreviations, acknowledgements of support, references, footnotes or equations. The abstract should not exceed 200 words.

    Keywords
    Three to six keywords should be provided.

    Introduction
    The introduction section should provide a context or background that gives a broad readership an overall outlook of the field and the research performed. It tackles a problem and states its important regarding with the significance of the study. Introduction can conclude with a brief statement of the aim of the work and a comment about whether that aim was achieved.

    Materials and Methods
    The materials and methods section provides the general experimental design and methodologies used. The aim is to provide enough detail to for other investigators to fully replicate your results. It is also required to facilitate better understanding of the results obtained. Protocols and procedures for new methods must be included in detail to reproduce the experiments.

    Ethics
    Ethics information, including IACUC permit numbers and/or IRB name, if applicable. This information should be included in a subheading labeled "Ethics Statement" in the "Methods" section of your manuscript file, in as much detail as possible.

    Results
    The result section focuses on the results of the experiments performed. This section can be divided into subsections.

    Discussion and Conclusion
    The discussion and conclusion section should provide the significance of the results and identify the impact of the research in a broader context. It should not be redundant or similar to the content of the results section. Use the conclusion section for interpretation only, and not to summarize information already presented in the text or abstract.

    Author Contributions
    The author contributions section describes the contribution of each author, designated by initials. For the case of co-first authors, description of each author’s contribution is required.

    Acknowledgements
    The acknowledgements section should acknowledge contribution(s) from non-authors and funding sources. It should also include a declaration of any conflict of interest.

    Supplementary Information
    The supplementary information section is optional and contains all materials and figures that have been excluded from the entire manuscript. The information is relevant to the manuscript but remains non-essential to readers’ understanding of the manuscript’s main content. All supplementary information should be submitted as a separate file in Step 4 during manuscript submission. Please ensure the file names of such files start with ‘Suppl_info_’.

    Text
    The text of the manuscript should be in Microsoft Word. The length of the manuscript cannot be more than 8000 words.

    In-text citations
    Reference citations in the text should be numbered consecutively in square brackets. Some examples:

    1. Negotiation research spans many disciplines [3,4].
    2. This result was later contradicted by Becker and Seligman [5].
    3. This effect has been widely studied [1–3,7].

    Personal communications and unpublished works can only be used in the main text of the submission and are not to be placed in the Reference section. Authors are advised to limit such usage to the minimum. They should also be easily identifiable by stating the authors and year of such unpublished works or personal communications and the word ‘Unpublished’ in parenthesis. E.g. (Smith J, 2000, Unpublished)

    References
    The references section is compulsory and should be placed at the end of all manuscripts. The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should be excluded from this section.

    The journal follows the Vancouver style of references. You can refer to the ICMJE Recommendation for preparing your references in the manuscript for submission. For references in the reference list, if the referred article has more than five authors, list only the first five authors and abbreviate the remaining authors to italicized ‘et al.’ (meaning: "and others"). Authors referenced are listed with their surname followed by their initials (e.g. Smith J). All references should be numbered (e.g. 1. 2. 3. etc.) and sequenced according to the order it appears as an in-text citation. References should follow the following pattern:

    • Journal article
      Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 2007; 117(1): 246–57. doi: 10.1172/JCI17645.
    • Non-English journal article
      Massone L, Borghi S, Pestarino A, Piccini R, Gambini C. Localisations palmaires purpuriques de la dermatite herpetiforme (French) [Purpuric palmar sites of dermatitis herpetiformis]. Ann Dermatol Venerol 1987; 114(12): 1545–1547.
    • Book
      Rojko JL, Hardy WD Jr. Feline leukemia virus and other retroviruses. In: Sherding RG (editors). The cat: diseases and clinical management. New York: Churchill Livingstone; 1989. p. 229–332.
    • Proceedings
      Sasaki Y, Nomura Y (editors). Symposium on Nasal Polyp; 1984 Oct 5–6; Tokyo. Stockholm: Almqvist & Wiksell; 1986. p. 48.
    • Dissertations
      Jones DL. The role of physical activity on the need for revision total knee arthroplasty in individuals with osteoarthritis of the knee [PhD thesis]. Pittsburgh (PA): University of Pittsburgh; 2001. p. 436.
    • Patents
      Blanco EE, Meade JC, Richards WD (inventors). Ophthalmic V (assignee). Surgical Stapling system. US patent. 4,969,591. 1990 Nov 13.
    • Websites
      Hypertension, Dialysis & Clinical Nephrology [Internet]. Hinsdale (IL): Medtext, Inc.; 1995–2001 [cited 2001 Mar 8]. Available from: http://www.medtext.com/hdcn.htm.

    Tables, Lists and Equations
    Tables created using Microsoft Word table function are preferred. The tables should include a title. Titles and footnotes/legends should be concise. These must be submitted together with the manuscript. Likewise, lists and equations should be properly aligned and its meaning clear to readers.

    Figures
    Figures include photographs, scanned images, graphs, charts and schematic diagrams. Figures submitted should avoid unnecessary decorative effects (e.g. 3D graphs) as well as be minimally processed (e.g. changes in brightness and contrast applied uniformly for the entire figure). It should also be set against a white background. Please remember to label all figures (e.g. axis etc.) and add in captions (outside the figure) as required. All figures must have a brief title (also known as caption) that describes the entire figure without citing specific panels, followed by a legend defined as description of each panel.

    The preferred file formats are TIFF and JPEG. All figures should be legible in print form and of optimal resolution. Optimal resolutions preferred are 300 dots per inch for RBG colored, 600 dots per inch for greyscale and 1200 dots per inch for line art. Although there are no file size limitation imposed, authors are highly encouraged to compress their figures to an ideal size without unduly affecting legibility and resolution of figures. This will also speed up the process of uploading in the submission system.

    The Editor-in-Chief and Publisher reserve the right to request from author(s) the high-resolution files and unprocessed data and metadata files should the need arise at any point after manuscript submission for reasons such as production, evaluation or other purposes. The file name should allow for ease in identifying the associated manuscript submitted.

  • Authors contributing to the journal agree to publish their articles under the Creative Commons Attribution-Noncommercial 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, that the work is not used for commercial purposes, and that in the event of reuse or distribution, the terms of this license are made clear.

  • The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Article Processing Charges (APC)

PiscoMed publishes all its journals in Gold Open Access format. The scientific community and the general public have free of all restrictions on accessing (e.g., subscription) and free of many restrictions on using its contents as soon as it is published online. PiscoMed does not require readers to purchase any form of subscription to view online versions of the journals. In order to defray our editorial and production costs, authors of the accepted articles are required to pay the article processing charges (APCs). The charges will come from authors' institutes or research funding bodies.

The APC for Reports in Clinical Studies and Medicine is as follows:

JournalAPC
Reports in Clinical Studies and MedicineUS $800

APC Payment

Payments for APC of this journal can be made through our online PayPal payment gateway. Enter the article no. into the below textbox and select "Pay Now" to proceed with payment.

*Article No.

*Article No. is mandatory for payment and it can be found on the acceptance letter issued by the Editorial Office. Payment without indicating Article No. will result in processing problem and delay in article processing. Please note that payments will be processed in USD. You can make payment through Masters, Visa or UnionPay card.




Announcements

No announcements have been published.
 
More Announcements...